StockNews.com Lowers Teradyne (NASDAQ:TER) to Sell
StockNews.com lowered shares of Teradyne (NASDAQ:TER – Free Report) from a hold rating to a sell rating in a research note released on Tuesday. Several other equities research analysts have also issued reports on the stock. JPMorgan Chase & Co. lifted their price target on shares of Teradyne from $120.00 to $145.00 and gave the […]
Microsoft (NASDAQ:MSFT) Price Target Raised to $505.00
Microsoft (NASDAQ:MSFT – Free Report) had its price objective boosted by KeyCorp from $490.00 to $505.00 in a report published on Friday morning, Marketbeat Ratings reports. The brokerage currently has an overweight rating on the software giant’s stock. A number of other brokerages have also weighed in on MSFT. Oppenheimer lowered Microsoft from an “outperform” […]
Robert W. Baird Boosts Core & Main (NYSE:CNM) Price Target to $60.00
Core & Main (NYSE:CNM – Free Report) had its price target upped by Robert W. Baird from $53.00 to $60.00 in a research note published on Wednesday morning, Benzinga reports. They currently have an outperform rating on the stock. A number of other equities analysts have also recently issued reports on the company. Wells Fargo […]
Syros Pharmaceuticals (NASDAQ:SYRS) Raised to “Hold” at StockNews.com
StockNews.com upgraded shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) from a sell rating to a hold rating in a research report sent to investors on Tuesday. SYRS has been the topic of several other research reports. HC Wainwright cut their price objective on Syros Pharmaceuticals from $15.00 to $6.00 and set a “buy” rating […]
Everi Holdings Inc. (NYSE:EVRI) Given Consensus Recommendation of “Hold” by Brokerages
Shares of Everi Holdings Inc. (NYSE:EVRI – Get Free Report) have been assigned a consensus rating of “Hold” from the five ratings firms that are presently covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation. The average 12 month target price among brokerages that have issued ratings on […]
Disc Medicine (NASDAQ:IRON) Earns “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their overweight rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research report report published on Tuesday, Benzinga reports. Cantor Fitzgerald currently has a $85.00 price target on the stock. IRON has been the subject of several other research reports. HC Wainwright restated a “buy” rating and issued a […]
Esperion Therapeutics (NASDAQ:ESPR) Upgraded by StockNews.com to “Buy”
StockNews.com upgraded shares of Esperion Therapeutics (NASDAQ:ESPR – Free Report) from a hold rating to a buy rating in a research note released on Tuesday. A number of other brokerages have also recently issued reports on ESPR. Bank of America cut Esperion Therapeutics from a “neutral” rating to an “underperform” rating and dropped their price […]
Hsbc Global Res Upgrades Illumina (NASDAQ:ILMN) to “Strong-Buy”
Illumina (NASDAQ:ILMN – Get Free Report) was upgraded by stock analysts at Hsbc Global Res from a “hold” rating to a “strong-buy” rating in a research note issued to investors on Thursday, Zacks.com reports. Other equities analysts have also recently issued reports about the stock. StockNews.com started coverage on shares of Illumina in a research […]
ASML (NASDAQ:ASML) Price Target Lowered to $790.00 at Wells Fargo & Company
ASML (NASDAQ:ASML – Free Report) had its price objective trimmed by Wells Fargo & Company from $1,000.00 to $790.00 in a research report sent to investors on Thursday, Benzinga reports. The firm currently has an overweight rating on the semiconductor company’s stock. Other analysts have also recently issued research reports about the stock. Berenberg Bank […]
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Upgraded at StockNews.com
Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a research report issued on Thursday. Other analysts have also issued reports about the stock. HC Wainwright reiterated a “buy” rating and issued a $60.00 price target on shares of Arrowhead Pharmaceuticals in a research […]
StockNews.com Lowers Fortinet (NASDAQ:FTNT) to Hold
Fortinet (NASDAQ:FTNT – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Thursday. Several other equities analysts have also recently commented on the stock. Morgan Stanley cut their target price on shares of Fortinet from $73.00 to $69.00 and set […]
last updated on 19 Oct 15:40